PMC:7600245 / 96174-96416
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T437 | 117-127 | Body_part | denotes | neutrophil | http://purl.org/sig/ont/fma/fma62860 |
T438 | 215-224 | Body_part | denotes | capillary | http://purl.org/sig/ont/fma/fma63194 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T48 | 215-224 | Body_part | denotes | capillary | http://purl.obolibrary.org/obo/UBERON_0001982 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T435 | 117-137 | Disease | denotes | neutrophil migration | http://purl.obolibrary.org/obo/MONDO_0008091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T959 | 24-30 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | Active |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T24627 | 0-13 | Chemical | denotes | Dexamethasone | http://purl.obolibrary.org/obo/CHEBI_41879 |
T716 | 14-22 | Chemical | denotes | Decadron | http://purl.obolibrary.org/obo/CHEBI_41879 |
T717 | 51-59 | Chemical | denotes | molecule | http://purl.obolibrary.org/obo/CHEBI_25367 |
T718 | 76-90 | Chemical | denotes | glucocorticoid | http://purl.obolibrary.org/obo/CHEBI_24261 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T193 | 117-137 | http://purl.obolibrary.org/obo/GO_1990266 | denotes | neutrophil migration |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T107 | 205-237 | Phenotype | denotes | increased capillary permeability | http://purl.obolibrary.org/obo/HP_0030005 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T795 | 0-242 | Sentence | denotes | Dexamethasone(Decadron, Active Injection D) Small molecule Stimulation of glucocorticoid receptors, suppression of neutrophil migration, suppression of inflammatory mediators production, and reversal of increased capillary permeability ~10 |